A recent study reported that RSPO1/LGR4 axis was involved in obesity-related renal fibrosis through promoting Wnt/β-catenin signaling pathway, providing a potential therapeutic target for the obesity-related chronic kidney disease (CKD) (Su et al., 2021). Here, RSPO1 is linked to obesity disorder.